Antineoplastic agents
Ref: 4Z-D-1951
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-D-7738
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-B-4346
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-P-2838
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-B-4324
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Irinotecan EP Impurity E-d3 (Irinotecan USP Related Compound B-d3, (S)-7-Ethyl-10-Hydroxy Camptothecin-d3)
Formula:
C22H17D3N2O5
Molecular weight:
395.45
Ref: 4Z-I-1841
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-I-1810
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-D-7758
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-D-3456
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Pomalidomide Related Compound 9 Triflate
CAS:2093388-21-5
Formula:
C16H18N4O4·C2HF3O2
Molecular weight:
330.34 114.02
Ref: 4Z-P-178033
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-P-129049
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-P-6844
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-C-11509
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-D-1939
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-D-1996
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-E-28102
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-P-2865
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Bevacizumab (Avastin)
CAS:216974-75-3
Formula:
C6638H1016N1720O2108S44
Color and Shape:
White To Off-White Solid
Molecular weight:
149196.82
Ref: 4Z-B-128001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-G-2620
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-A-293002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024